Physician profile
Patrick John Boyle
NPI 1487386058
$1,357.16
in general payments reported to CMS, 2019-2025
9 companies · $101 in 2025
The $101 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $259 · 2024: $998 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,220 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,220.15 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $351.14 | 2023-2025 | Dalvance |
| Inari Medical, INC. | $295.88 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $212.48 | 2024 | Xarelto |
| Medical Device Business Services, INC. | $137.01 | 2024 | |
| Fisher & Paykel Healthcare INC | $107.79 | 2023-2024 | Fisher & Paykel Healthcare |
| Csl Behring | $106.21 | 2023 | Kcentra |
| Astrazeneca Pharmaceuticals Lp | $68.88 | 2023 | Andexxa |
| Ethicon US, LLC | $49.93 | 2024 | Dermabond |
| Pfizer INC. | $27.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.